SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,645,734 | +15.3% | 252,867 | +4.6% | 0.02% | +21.1% |
| Q2 2023 | $46,546,836 | +136.0% | 241,852 | +148.3% | 0.02% | +137.5% |
| Q1 2023 | $19,720,983 | +107.0% | 97,402 | +31.4% | 0.01% | +100.0% |
| Q4 2022 | $9,528,759 | -5.9% | 74,148 | +0.2% | 0.00% | -20.0% |
| Q3 2022 | $10,125,000 | -46.0% | 73,995 | -30.2% | 0.01% | -44.4% |
| Q2 2022 | $18,760,000 | -21.1% | 106,022 | -35.8% | 0.01% | 0.0% |
| Q1 2022 | $23,788,000 | -20.2% | 165,137 | -14.3% | 0.01% | -18.2% |
| Q4 2021 | $29,793,000 | +43.4% | 192,711 | +57.5% | 0.01% | +37.5% |
| Q3 2021 | $20,771,000 | +74.6% | 122,324 | +62.3% | 0.01% | +60.0% |
| Q2 2021 | $11,896,000 | +3.9% | 75,348 | -8.6% | 0.01% | 0.0% |
| Q1 2021 | $11,445,000 | -13.1% | 82,420 | +9.6% | 0.01% | -16.7% |
| Q4 2020 | $13,174,000 | – | 75,218 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |